P
rostaglandins are critical regulators of vascular tone and arterial pressure. [1] [2] [3] [4] [5] Inhibition of endogenous prostaglandin synthesis by NSAIDs may result in systemic hypertension or compromise the control of blood pressure in subjects with preexisting salt-sensitive hypertension. 3, 5 Prostaglandin E 2 (PGE 2 ) is a potent vasodilator in several vascular beds and directly relaxes preconstricted vascular rings. 6 Conversely, PGE 2 directly constricts smooth muscle in other tissues, including ileum and vas deferens. 7, 8 These opposing effects of PGE 2 are thought to be mediated by distinct G-protein-coupled E-prostanoid (EP) receptors, designated EP 1 , EP 2 , EP 3 , and EP 4 . 7 These receptors may be distinguished by their functional effects and by their affinity for structural analogues of PGE 2 . At least 2 constrictor EP receptors, designated EP 1 and EP 3 , exist. [7] [8] [9] [10] [11] The EP 1 receptor signals through increased cell calcium and is highly active in vas deferens and ileal smooth muscle. 7, 8, 12, 13 The EP 3 receptor signals through an inhibitory G protein (G i ) to decrease cAMP and is selectively activated by MB28767 and SC46275. 11, 14, 15 There are also 2 distinct EP receptors that relax smooth muscle, designated EP 2 and EP 4 . 16,17 EP 2 and EP 4 receptors directly dilate vascular smooth muscle rings in vitro. 16, 17 Both these receptors increase cAMP but may be distinguished by their differential sensitivity to the EP 2 -selective agonist butaprost and the EP 4 -selective agonist prostaglandin E 1 (PGE 1 )-OH. 15, 17 An important role for EP receptors in regulating systemic blood pressure has been suggested by recent studies in mice with targeted disruption of these receptors. Disruption of the EP 2 receptor is associated with the development of saltsensitive hypertension. 18 Importantly, these mice also displayed an aberrant effect of PGE 2 infusion on MAP, which increased blood pressure in EP 2 knockout mice as opposed to the typical decrease in blood pressure observed in control mice. 18 This finding suggests the importance of both pressor and depressor EP receptors in regulating systemic blood pressure. Recent studies have determined the affinity of prostaglandin analogues for all the cloned mouse prostanoid receptors, facilitating the interpretation of pharmacological studies examining the role of EP receptors in mice. 15 The present studies were undertaken to pharmacologically characterize the pressor and depressor EP receptors mediating the hemodynamic effects of PGE 2 infusion in the mouse.
Methods

Chemical Reagents
PGE 2 and PGE 1 -OH were purchased from Biomol. Sulprostone was provided by Berlex Laboratories (Cedar Knolls, NJ). MB28767, which was generously provided by Michael Caton (Rhone-Poulanc Rorer, Dagenham, England), and SC46275, which was provided by Drs Richard Marks and Edward Drower (Searle R&D, Skokie, Ill), were dissolved in ethanol.
Animal Preparation
C57BL/6 mice were purchased from Harlan (Indianapolis, Ind). EP 2 -deficient mice were developed as previously described. 18 F 2 wild-type (EP 2 ϩ/ϩ ) and EP 2 -null (EP 2 Ϫ/Ϫ ) mice were littermates produced from intercrossing F 1 heterozygous (EP 2 ϩ/Ϫ ) mice. Experiments were conducted in male mice age 8 to 12 weeks. All mice were weaned at 3 weeks of age and fed a standard chow diet. Mice were housed under controlled conditions (temperature 21Ϯ1°C, humidity 60Ϯ10%, lighting for 8 to 20 hours). Genotypes of mice were routinely determined by Southern analysis of genomic tail DNA. The wild-type (4.3-kb) and recombinant (7.5-kb) XbaI fragments were identified by using a 3Ј XbaI/SacI fragment as a probe.
Blood Pressure Measurement
Male F 2 EP 2 ϩ/ϩ and EP 2 Ϫ/Ϫ mice and C57BL/6 mice, age 12 to 16 weeks and 20 to 25 g in body weight, were anesthetized with 80 mg/kg ketamine (Fort Dodge Laboratories) and 8 mg/kg inactin (BYK) by intraperitoneal administration. Mice were placed on a temperature-controlled pad. After tracheostomy, PE-10 tubing was inserted into the right carotid artery, a jugular vein catheter was placed for infusion, and a urinary bladder catheter was inserted for urine collection. Blood pressure was measured with a Cobe CDX II transducer connected to a blood pressure analyzer (BPA 400, Micromed). The readings of blood pressure and heart rate were equilibrated for 30 to 60 minutes until stable values were obtained. The test agents (PGE 2 , sulprostone, MB28767, SC46275, and PGE 1 -OH) were mixed with 25 L of saline and injected as a bolus via the jugular vein over Ϸ20 seconds. Blood pressures, including systolic, diastolic, and mean arterial pressure (MAP), and heart rates were recorded continuously on a thermal printer or computerized data record.
For measurement of blood pressure in conscious mice, we followed the technique of Mattson. 19 Animals were preanesthetized with methoxyflurane and sodium pentobarbital (50 mg/kg IP). With use of an aseptic technique, femoral artery catheters were placed for MAP measurement, and femoral venous catheters were placed for infusion. Three days after surgery, PGE 2 (200 g/kg) or SC46275 (20 g/kg) was administered as a 100 L bolus, and blood pressure was recorded by use of a Cobe CDX II transducer (described above).
Preparation of cDNA Probes
Mouse EP 1 (649-bp), EP 2 (420-bp), EP 3 (438-bp), and EP 4 (350-bp) cDNA fragments were generated by reverse transcription-polymerase chain reaction from mouse kidney and ileum total RNA and were cloned into pCR-TOPO vector (Invitrogen). Rabbit EP 1 (223-bp), EP 2 (345-bp), EP 3 (466-bp), and EP 4 (368-bp) cDNA fragments were also generated by reverse transcription-polymerase chain reaction from rabbit kidney and uterus and were also cloned into pCR-TOPO vector (Invitrogen). Mouse ␤-actin cDNA was obtained from Ambion Inc. Antisense and sense riboprobes were synthesized in vitro with the use of an appropriate RNA polymerase (Maxiscript, Ambion) and [ 
Solution Hybridization/RNase Protection Assay
RNase protection assays were performed as described previously. 20 Briefly, plasmids containing rabbit or mouse EP 1 , EP 2 , EP 3 , and EP 4 and rabbit GAPDH or mouse ␤-actin inserts, described above, were linearized with appropriate restriction enzymes. 4 cpm labeled riboprobes. After hybridization, ribonuclease digestion was carried out at 37°C for 30 minutes, and precipitated protected fragments were separated on 4% polyacrylamide gel at 200 V for 3 hours. The gel was exposed to Kodak XAR-5 film overnight at Ϫ80°C with intensifying screens.
Isolation of Renal Microvessels
Renal preglomerular microvessels were isolated by following the method of Chaudhari and Kirschenbaum. 21 The renal artery of anesthetized New Zealand White rabbits was cannulated, and kidneys were perfused with 10 mL of ice-cold normal saline, followed by 10 mL of a 1% suspension of magnetized iron oxide (Fe 3 O 4 , Aldrich) in normal saline. The cortex of the kidneys was minced with a tissue press and homogenized with a Polytron homogenizer (Brinkmann) at moderate speed for 15 seconds twice. Microvessels were separated from nonvascular tissue in several washing steps (in 1ϫ PBS) with the help of a strong magnet held to the outside of the tube. Washing and separation were repeated after passing the homogenate through 20-, 21-, and 23-gauge needles, respectively, until the suspension was mostly free of glomeruli and other nonvascular tissue. This technique provided a large quantity of relatively pure preglomerular microvessels, with 10% to 15% of the suspension consisting of attached glomeruli and small fragments of early proximal tubules.
Results
Different Effects of PGE 2 on Blood Pressure in Mice
The dose-dependent effect of PGE 2 on MAP pressure was determined in male mice (Table) ously observed in female mice 22 and demonstrate the existence of both pressor and depressor EP receptors in mice.
EP 3 Agonists Are Potent Vasopressors
The dose-dependent effects of intravenous infusion of 3 EP 3 receptor agonists, sulprostone (EP 3 ϾEP 1 ), MB28767 (EP 3 ), and SC46275 (EP 3 ) on MAP were examined. As shown in the Table, all 3 EP 3 agonists significantly increased MAP. Both MB28767 and SC46275 infusion (1 to 10 g/kg) resulted in a prompt and marked increase in MAP with a progressive return to baseline over 15 minutes (Figure 2) . Similarly, sulprostone, a pressor agonist that acts at the EP 1 and EP 3 receptors, increased MAP in wild-type and EP 2 Ϫ/Ϫ mice, as previously reported. 18 Likewise the pressor effects of 2 EP 3 agonists, MB28767 and SC46275, seen in EP 2 ϩ/ϩ mice were identical in EP 2 Ϫ/Ϫ mice (Table) . These pressor effects are not specific for anesthetized mice because SC46275 (20 g/kg) also increased MAP in conscious chronically catheterized mice, from 121.7Ϯ8. 6 
Desensitization of Pressor Effects With Use of EP 3 -Specific Agonist SC46275
Experiments were designed to determine whether prior exposure to a pressor dose of an EP 3 -selective agonist desensitized mice to the subsequent effects of a second pressor agonist ( Figure 3A) . Pretreatment of mice with 10 g/kg SC46275 transiently increased MAP as described above and completely prevented the subsequent pressor effect of sulprostone (20 g/kg) on MAP. As also described above, EP 2 Ϫ/Ϫ mice characteristically show a pressor response to infusion of 100 g/kg PGE 2 ( Figure 1) ; in contrast, wild-type animals react with a decrease in blood pressure. Prior desensitization with SC46275 (10 g/kg) in EP 2 Ϫ/Ϫ mice changed the effect of PGE 2 from a pressor to a depressor response ( Figure 3B) 
EP 4 Receptor Agonist PGE 1 -OH Is Vasodepressor
To pharmacologically characterize and determine whether this depressor receptor could be activated in mice without prior desensitization, the effect of an EP 4 -selective agonist, PGE 1 -OH, was examined. In contrast to the pressor effects of native PGE 2 in EP 2 Ϫ/Ϫ mice, intravenous administration of PGE 1 -OH, decreased MAP in both wild-type and EP 2 Ϫ/Ϫ mice to a similar extent (Table and Figure 4 ). At a dose of 100 g/kg PGE 1 -OH, infusion resulted in a prompt fall in MAP, which was maximal within 1 minute and then gradually returned to baseline. The maximal decrease in MAP was not significantly different in wild-type mice and EP 2 Ϫ/Ϫ mice.
Expression of EP Receptor mRNA in Blood Vessels
RNase protection assays were performed to determine the relative expression of mRNA for the 4 EP receptors in mouse aorta and rabbit preglomerular renal vessels. Expression of the EP 3 receptor mRNA predominated in both vessels, exhibiting a much stronger signal than the other potential constrictor receptor, the EP 1 receptor ( Figure 5 ). Nuclease protections of mRNA from rabbit preglomerular vessels were repeated on 3 separate preparations. Densitometry normalized to GAPDH demonstrates that rabbit EP 3 receptor mRNA is 7.7Ϯ0.7-fold more abundant than rabbit EP 4 receptor mRNA and 47.8Ϯ3.8-fold more abundant than EP 2 receptor mRNA (both Ϫ/Ϫ (छ) mice. PGE 2 (100 g/kg) was infused intravenously at timeϭ0 seconds as described in Methods. *PϽ0.05 vs baseline MAP (paired t test). MAP did not change in mice receiving vehicle alone (not shown).
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PϽ0.005 by ANOVA). A similar pattern of expression was observed in mouse aortas.
Discussion
Accumulating evidence supports an important role for vasodilator prostanoids in preventing hypertension in humans. 3, 23 Control of blood pressure in patients with essential hypertension is particularly dependent on endogenous vasodilator prostaglandins. 22 In mice with targeted disruption of the angiotensin type 2 receptor, increased synthesis of dilator prostaglandins, including PGE 2 , helps maintain normotension, and these mice develop hypertension when treated with an NSAID. 24 The prostanoid receptors maintaining normotension and mediating these dilator responses have been only partially characterized. Targeted disruption of the EP 2 receptor is associated with the development of salt-sensitive hypertension in EP 2 Ϫ/Ϫ but not wild-type mice. 18 Those studies also found that the normal vasodepressor effect of the EP 2 -selective agonist butaprost was absent in EP 2 Ϫ/Ϫ mice. Furthermore, when PGE 2 , an endogenous ligand, was infused in EP 2 Ϫ/Ϫ mice, it increased arterial pressure rather than producing the typical vasodepressor effect observed in EP 2 ϩ/ϩ mice. These findings point to the existence of the regulation of blood pressure by multiple EP receptors. The present studies were designed to further characterize the prostaglandin E receptor subtypes regulating arterial pressure in the mouse.
Initial studies confirmed that PGE 2 infusion increased mean arterial pressure in male EP 2 Ϫ/Ϫ mice in a manner similar to that previously reported for female EP 2 Ϫ/Ϫ mice. 18 Conversely, PGE 2 functioned as a vasodepressor in male EP 2 ϩ/ϩ mice. Thus, disruption of the EP 2 Ϫ/Ϫ receptor converts the dominant effect of PGE 2 from a vasodepressor to a vasopressor. Some studies have suggested that the female circulation exhibits greater sensitivity to the hemodynamic effects of prostaglandins than does the male circulation. 25 The present findings suggest that this possibility holds true for the effect of PGE 2 on MAP, because there was a tendency for the depressor effect of PGE 2 in male EP 2 ϩ/ϩ mice to be less than in female EP 2 ϩ/ϩ mice (⌬MAP after PGE 2 was Ϫ10.3Ϯ3.2 mm Hg in males versus Ϫ19.2Ϯ5.2 mm Hg in females). However, this trend did not achieve statistical significance. Further studies are required to determine whether gender influences the extent of these changes. Regardless of these considerations, the qualitative effect of PGE 2 on MAP appears similar in female and male EP 2 ϩ/ϩ mice, in which it acts as a vasodepressor, compared with EP 2 Ϫ/Ϫ mice, in which it acts as a vasopressor. The present studies found a potent pressor effect of 2 highly selective EP 3 agonists, MB28767 and SC46275. SC46275 is Ϸ10
6 -fold more potent at EP 3 receptors than at EP 1 receptors, 11 activating EP 1 receptors in ileal smooth muscle only at concentrations Ն30 mol/L, whereas sulprostone comparably activates EP 1 receptors at 20 nmol/L. 11 The potent vasopressor effect of SC46275 suggests an EP 3 -rather than an EP 1 -mediated effect. Similar findings with MB28767 support this conclusion. Molecular characterization of all the cloned murine prostanoid receptors show that MB28767 binds the EP 3 receptor 200-fold more avidly than the EP 1 receptor or any other prostanoid receptor. 15 These findings confirm and extend previous studies with the EP 1/3 -selective agonist, sulprostone, 18 and point to a specific role for the EP 3 receptor in regulating vascular tone.
The 3 EP 3 agonists used also appear to act via a common mechanism, because pretreatment with an EP 3 -selective agonist prevented the pressor response to a second EP 3 agonist ( Figure 3A ). The precise mechanism of desensitization remains uncertain but could be consistent with studies showing agonist-induced desensitization and internalization of the cloned mouse EP 3 receptor expressed in COS cells. 26 Alternatively, the persistence of the EP 3 agonist (SC46275) in the circulation because of poor metabolic clearance could lead to ongoing receptor activation. 27 Regardless of the desensitization mechanism, pretreatment with EP 3 -selective analogues did not block the subsequent vasodepressor effect of PGE 2 , supporting a distinct mechanism for this effect ( Figure 3B ). It is of note that after SC46275 "desensitization" of the vasopressor E-prostanoid response, a remaining vasodepressor effect of PGE 2 in EP 2 Ϫ/Ϫ mice was revealed. This supports the persistence of a separate vasodepressor EP receptor in EP 2 Ϫ/Ϫ mice, possibly the EP 4 receptor. This conclusion is further supported by the observation that even without prior desensitization, PGE 1 -OH, an EP 4 -selective agonist, was a depressor in EP 2 Ϫ/Ϫ mice. Interestingly, after pretreatment with SC46275, the vasodepressor effect of PGE 2 is significantly greater in EP 2 ϩ/ϩ mice than in EP 2 Ϫ/Ϫ mice, consistent with the possibility that PGE 2 activates both EP 2 and EP 4 depressor receptors in EP 2 ϩ/ϩ mice but only the EP 4 receptor in EP 2 Ϫ/Ϫ mice. Multiple mechanisms undoubtedly contribute to the effects of PGE 2 on blood pressure in the intact animal, including effects on sympathetic nervous activity and renin release and direct effects on vascular tone. 6,28 -30 The present studies used nuclease protection to demonstrate that EP receptor mRNA is expressed in mouse and rabbit vasculature. These studies demonstrate that EP 3 receptor mRNA was expressed at significantly higher levels than the EP 1 , EP 2 , and EP 4 receptor mRNAs. Although it is uncertain whether this EP receptor mRNA expression pattern parallels receptor density, these findings support the results of functional studies suggesting roles for the EP 2 , EP 4 , and EP 3 receptors in modulating blood pressure. Furthermore, the presence of EP receptor mRNAs in the vasculature suggests that direct effects on vascular tone may contribute to the observed effects of PGE 2 infusion on MAP. They additionally support a specific role for the EP 3 receptor as a vasopressor receptor in rabbit renal resistance arterioles.
In summary, the present studies provide evidence that the net effect of PGE 2 infusion on blood pressure results from a balance between the functional activity of at least 3 distinct EP receptors. Data using an EP 4 -selective analogue and EP 2 Ϫ/Ϫ mice support independent roles for EP 2 and EP 4 receptors as vasodepressors in the mouse circulation. These findings also suggest a critical role the EP 3 receptor as an important vasopressor receptor. No functional evidence supports an independent role for the EP 1 receptor as a vasopressor. Given the importance of prostaglandin E receptors in the regulation of blood pressure, 18, 24 selective agonists and antagonists of vasoactive EP receptors may provide important new therapeutic targets for the treatment of hypertension.
Note Added in Proof
After this manuscript was submitted, another study documenting the role of EP receptors as vasopressors and vaso- 3 , and EP 4 mRNA expression in mouse aortas and rabbit preglomerular vessels. Tissue from 10 pooled mouse aortas or 3 separate rabbit preglomerular arterial preparations was collected, and total RNA was extracted and analyzed as described in Methods. Top panels show nuclease protection for EP 1 , EP 2 , EP 3 , and EP 4 . RNA loading equivalency was assessed by simultaneous use of ␤-actin (mouse) or GAPDH (rabbit) riboprobes (bottom panels). The rabbit nuclease protection is representative of 3 separate preparations.
depressors in knockout mice was published by Audoly et al (Am J Physiol. 1999;277:H924 -H930).
